JP2010523596A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523596A5
JP2010523596A5 JP2010502341A JP2010502341A JP2010523596A5 JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5 JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkylenyl
conr
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523596A (ja
JP5347164B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059505 external-priority patent/WO2008124651A2/en
Publication of JP2010523596A publication Critical patent/JP2010523596A/ja
Publication of JP2010523596A5 publication Critical patent/JP2010523596A5/ja
Application granted granted Critical
Publication of JP5347164B2 publication Critical patent/JP5347164B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502341A 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤 Expired - Fee Related JP5347164B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92193207P 2007-04-05 2007-04-05
US60/921,932 2007-04-05
US96425407P 2007-08-10 2007-08-10
US60/964,254 2007-08-10
PCT/US2008/059505 WO2008124651A2 (en) 2007-04-05 2008-04-04 Nitro-imidazole hypoxia imaging agents

Publications (3)

Publication Number Publication Date
JP2010523596A JP2010523596A (ja) 2010-07-15
JP2010523596A5 true JP2010523596A5 (enExample) 2011-05-12
JP5347164B2 JP5347164B2 (ja) 2013-11-20

Family

ID=39831553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502341A Expired - Fee Related JP5347164B2 (ja) 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤

Country Status (7)

Country Link
US (2) US7807394B2 (enExample)
EP (1) EP2132200B1 (enExample)
JP (1) JP5347164B2 (enExample)
KR (1) KR101523257B1 (enExample)
CN (1) CN101652360B (enExample)
CA (1) CA2683433C (enExample)
WO (1) WO2008124651A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101652360B (zh) * 2007-04-05 2014-06-25 美国西门子医疗解决公司 硝基咪唑低氧造影剂
CN101709060B (zh) * 2009-12-02 2013-05-01 北京师范大学 一种f-三唑环-聚乙二醇-甲硝唑化合物及其制备方法
CN102858752B (zh) 2010-02-08 2018-10-16 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
EP2556372A1 (en) 2010-04-08 2013-02-13 Siemens Medical Solutions USA, Inc. Synthesis of 18f-labeled tracers in hydrous organic solvents
US10639608B2 (en) 2010-04-08 2020-05-05 Siemens Medical Solutions Usa, Inc. System, device and method for preparing tracers and transferring materials during radiosynthesis
CN101921263A (zh) * 2010-04-16 2010-12-22 兰州大学 2-硝基咪唑衍生物及其用途和制备方法
RU2710736C2 (ru) 2010-05-11 2020-01-10 Лантеус Медикал Имэджинг, Инк. Композиции, способы и системы для синтеза и применение визуализирующих средств
KR102527562B1 (ko) 2011-09-09 2023-05-03 랜티우스 메디컬 이메징, 인크. 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
US9061143B2 (en) 2011-10-14 2015-06-23 Sumitomo Heavy Industries, Ltd. Charged particle beam irradiation system and charged particle beam irradiation planning method
WO2014007650A1 (en) * 2011-12-23 2014-01-09 Auckland Uniservices Limited Compounds and methods for selective imaging and/or ablation
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
WO2015104589A1 (en) 2014-01-13 2015-07-16 Shanghai Lawring Biomedical Co., Ltd Dendrimer compositions, methods of synthesis, and uses thereof
WO2016047424A1 (ja) * 2014-09-25 2016-03-31 日本メジフィジックス株式会社 腎イメージング剤
WO2016179117A1 (en) * 2015-05-01 2016-11-10 Vanderbilt University Composition and method for detecting hypoxia
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
CN106977501A (zh) * 2017-03-20 2017-07-25 华东师范大学 一种基于2‑硝基咪唑‑1‑烷基醇的低氧激活前药
FR3068695B1 (fr) * 2017-07-05 2019-08-16 Centre National De La Recherche Scientifique Composes utiles comme agent d'imagerie de l'hypoxie
CA3076256A1 (en) * 2017-09-19 2019-03-28 The Governors Of The University Of Alberta Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy
US20200276338A1 (en) * 2017-09-19 2020-09-03 The Governors Of The University Of Alberta Bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their applications in multimodal theranostic management of hypoxia diseases including cancer
WO2021138540A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
CN111233821B (zh) * 2020-01-20 2022-12-27 上海交通大学医学院附属仁济医院 含3-羟基苯甲酸基团的新抗霉素衍生物及其制备方法和应用
CN114478489B (zh) * 2022-01-18 2023-04-28 中国科学院精密测量科学与技术创新研究院 一种氟-19修饰的硝基咪唑化合物及其衍生物的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US5721265A (en) * 1994-08-05 1998-02-24 Sri International Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
DE60022058T2 (de) * 1999-08-11 2006-06-01 Universite Catholique De Louvain Verfahren zur herstellung von [18f] radiomarkierten nitroimidazol-derivaten zum nachweis zellulärer hypoxie
CN101652360B (zh) * 2007-04-05 2014-06-25 美国西门子医疗解决公司 硝基咪唑低氧造影剂

Similar Documents

Publication Publication Date Title
JP2010523596A5 (enExample)
JP2009541403A5 (enExample)
JP2010504301A5 (enExample)
JP2010501534A5 (enExample)
JP2010538767A5 (enExample)
JP2011506530A5 (enExample)
JP2010505891A5 (enExample)
HRP20140667T4 (hr) Nukleozid fosforamidat prolijekovi
JP2009529091A5 (enExample)
JP2009539914A5 (enExample)
JP2008515616A5 (enExample)
JP2011526312A5 (enExample)
LU92376I2 (fr) Alogliptin sous toutes ses formes telles que protégées par le brevet de base, combiné avec pioglitazone sous toutes ses formes telles que protégées par le brevet de base
JP2011136981A5 (enExample)
JP2009524695A5 (enExample)
JP2010524750A5 (enExample)
JP2009542225A5 (enExample)
JP2013500200A5 (enExample)
JP2013527474A5 (enExample)
JP2012042477A5 (enExample)
JP2010529364A5 (enExample)
JP2013501834A5 (enExample)
JP2010285401A5 (enExample)
JP2011016798A5 (enExample)
JP2006525972A5 (enExample)